ATRX, AFF2, KCNQ2, SCN2A, and ASTN2
|
Homozygous deletion
|
Reduced synaptic activity
|
[53]
|
CACNA1C
|
ASD-related mutations
|
Disrupted interneurons migration
|
[54]
|
CNTN5 and EHMT2+
|
Heterozygous deletion
|
Hyperexcitability.
|
[55]
|
CNTNAP2
|
Heterozygous deletion
|
Increased neuronal network activity
|
[56]
|
FMR1
|
Heterozygous deletion
|
Impaired retinoic acid (RA)-dependent homeostatic synaptic plasticity
|
[57]
|
MECP2
|
Heterozygous deletion or duplication
|
Altered synaptic density, altered calcium signaling; altered neuronal firing rate and synchronization; delayed GABA switch
|
[58,59,60,61]
|
NLGN4
|
Gene overexpression and ASD-related mutations
|
Increased excitatory synapse density, altered synaptic strength
|
[62, 63]
|
NRXN1α
|
Homozygous and heterozygous deletion, ASD-related mutations
|
Impaired synaptic strength, altered synaptic calcium signaling
|
[64,65,66]
|
SHANK2
|
Heterozygous deletion and ASD-related mutations
|
Hyperconnectivity, enhanced branching complexity, increased synapse density
|
[67]
|
SHANK3
|
Heterozygous deletion and ASD-related mutations
|
Hypoconnectivity, reduced synaptogenesis, and dendritic arborization; impaired neuronal excitability and excitatory synaptic transmission; impaired HCN channels
|
[68,69,70,71,72,73,74]
|
TSC1/2
|
Homozygous and heterozygous deletion
|
Altered neuronal excitability and activity, altered synchrony (cortical neurons); hypoexcitability (cerebellar Purkinje cells)
|
[75,76,77,78]
|
Other ASD models
| |
Aberrant neuronal maturation, altered neuronal differentiation and synaptic formation
|
[79, 80]
|